Podcast appearances and mentions of april armstrong

In this episode of Derms and Conditions, Dr James Q Del Rosso is joined by Dr April Armstrong, Chair of Dermatology at UCLA, for a thorough discussion of oral therapies for plaque psoriasis—what's new, what still works, and how to choose the right treatment for the right patient. They kick off with a practical discussion on older systemic options like methotrexate and cyclosporine, including when these tried-and-true agents still have a place in modern practice. From there, Dr Armstrong walks through the evolving role of apremilast, particularly in hard-to- treat variants like palmoplantar pustulosis and in patients with milder disease who prefer oral options. The pair then take listeners through the clinical data behind deucravacitinib, a selective TYK2 inhibitor, highlighting its strong efficacy, minimal lab monitoring, and newly released five- year safety results. The conversation also covers real-world patient selection, payer considerations, and how clinicians can use guidelines to support access to newer therapies. Whether you're looking to refine your psoriasis treatment strategy or better counsel patients on long-term safety, this episode delivers practical pearls you can use in clinic tomorrow.

In this special live episode of Derms and Conditions, recorded at the 2025 Winter Clinical Dermatology Conference - Hawaii®, host Dr James Q. Del Rosso welcomes Dr April Armstrong, chief of dermatology at UCLA, and Dr David Cohen, dermatologist at NYU Langone, to break down the key takeaways from this year's meeting.   The discussion kicks off with chronic hand eczema, a condition that can be difficult to diagnose and treat due to its multiple causes. Dr Cohen highlights emerging data on new treatment options, including dupilumab, topical JAK inhibitors like ruxolitinib, and upcoming therapies like delgocitinib. They explore whether these newer therapies could be effective across different causes of hand eczema, even when an allergen isn't clearly identified.   Dr Armstrong then shifts the conversation to the next frontier in psoriasis treatment, including new oral therapies that are pushing efficacy to higher levels. They discuss IL-23 receptor antagonists, IL-17 inhibitors, and TNF inhibitors in development, as well as 5-year safety and efficacy data for deucravacitinib, which shows no long-term need for routine monitoring. The group also tackles the evolving treatment landscape for hidradenitis suppurativa (HS), where combination therapy is emerging as a key strategy. Dr Armstrong shares insights into guidance from the HS Foundation and the potential of pairing JAK inhibitors with IL-17 or TNF inhibitors for refractory cases.   They wrap up with practical pearls from the conference, including extended terbinafine treatment durations for fungal infections, pediatric biologic use around live vaccines, and the latest treatment options for molluscum contagiosum.   Tune in to this information-packed episode for expert insights and clinical updates straight from Winter Clinical 2025!

Therapeutic advancements make it possible for more people to get control of HS, but significant challenges to diagnosis and long-term management remain. Alexa Hetzel, MS, PA-C provides an overview of medical and procedural treatment options and emphasizes the importance of spending time with patients and letting them know you are their ally in care. Plus, April Armstrong, MD, MPH gives an update on OX inhibitors, and Sandri Johnson, MSN, FNP-BC addresses approaches to vitiligo treatment.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.

What happens when patients with psoriasis present with comorbidities and concomitant medical concerns? The availability of numerous treatments with differing mechanisms of action means that prescribers have more opportunity than ever before to help patients manage their disease safely, says April Armstrong, MD, MPH. Plus, Biologic Coordinator Neo Cuellar discusses therapeutic access and Hilary Baldwin, MD discusses skin care for patients with acne and rosacea.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.

In this special live episode of Derms and Conditions, recorded at the Fall Clinical Dermatology 2024 Meeting, host Dr James Q. Del Rosso welcomes Dr April Armstrong, chief of dermatology at UCLA, to discuss key highlights from the conference. Together, they cover the latest in psoriasis treatments, promising developments for vitiligo, advances in hidradenitis suppurativa, and much more. The discussion kicks off with psoriasis, where exciting progress in oral TYK2, IL-23, and IL-17A inhibitors is providing potential for effective, safe options for moderate-to-severe cases. For atopic dermatitis, they review the recent approval of lebrikizumab and the real-world efficacy of tralokinumab for head and neck involvement. They also spotlight OX40/OX40 ligand inhibitors—amlitelimab and rocatinlimab—as promising long-acting treatments currently in development. In prurigo nodularis, the newly approved nemolizumab, an IL-31 inhibitor, offers antifibrotic benefits and has notably not shown evidence of conjunctivitis risk seen with other biologics. For vitiligo, BET inhibitors are creating new opportunities by targeting epigenomics, and several JAK inhibitors are pending phase 3 data. For hidradenitis suppurativa, focus has shifted from TNF inhibitors to IL-17 inhibitors like secukinumab, with bimekizumab and oral JAK inhibitors, including povarcitinib, in late-stage development. They round out the episode with chronic hand eczema, where topical ruxolitinib and delgocitinib—a pan-JAK inhibitor recently approved in Europe—show encouraging results. Tune in to the full episode for a full recap of these developments and other breakthroughs from the Fall Clinical Dermatology 2024 Meeting!

In episode 30 of Cutaneous Miscellaneous, host Nicholas Brownstone, MD, welcomes April Armstrong, MD, Professor and Chief of Dermatology at UCLA, for a detailed discussion on oral therapies for psoriasis and their continued relevance in today's treatment landscape. They begin with a board review of 2 classic therapies, methotrexate and cyclosporine, breaking down their mechanisms of action, dosing protocols, key adverse effects, and important monitoring guidelines. They then explore methotrexate's continued use, particularly for uninsured patients, and cyclosporine's role as a short-term “bridging” therapy for patients in crisis. They review acitretin, discussing its risks, chemopreventive benefits, and lab monitoring requirements; apremilast, highlighting its safety and lack of required lab monitoring; and deucravacitinib, a TYK-2 inhibitor noted for its unique mechanism, long-term efficacy, and suitability for challenging psoriasis types. Tune in to hear expert guidance on navigating these oral therapies, practical tips for residents, and updates on how each therapy fits into modern psoriasis care!

Join Drs. April Armstrong and Lisa Beck for a conversation around the long-term burden and effects of AD. They will discuss the underlying pathophysiology of AD and how early intervention may impact disease course. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. Disclaimer:  This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits Speaker disclosures: April Armstrong, MD, MPH has served as a research investigator, scientific advisor, or speaker to AbbVie, Amgen, Almirall, Arcutis, ASLAN, Beiersdorf, BI, BMS, EPI, Incyte, Leo, UCB, Janssen, Lilly, Mindera, Nimbus, Novartis, Ortho, Sun, Dermavant, Dermira, Sanofi, Takeda, Organon, Regeneron, Pfizer and Ventyx Lisa Beck MD, consults for Abbvie, Allakos, Arcutis Biotherapeutics, Arena Pharmaceuticals, Aslan Pharma, Astria Therapeutics, Celldex, Dermavent, DermTech, Escient Pharma, Eli Lilly Company, Evelo Biosciences, Galderma, Incyte, Janssen, LEO Pharma, Merck, Nektar Therapeutics, Numab Therapeutics, Pfizer, Proteologix, Rapt Therapeutics, Regeneron, Ribon Therapeutics, Sanofi/Genzyme, Sanofi-Aventis, Sitryx Therapeutics, Stealth BioTherapeutics, Trevi Therapeutics, Union Therapeutics, Xencor and Yuhan and has been an Investigator for Abbvie, Astra-Zeneca, DermTech, Kiniksa, Pfizer, Regeneron, Ribon Therapeutics and Sanofi.  © 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2401395 - 1.0 - 07/2024 MAT-US-2407636 v1.0 - P Exp Date: 07/31/2026

Books That Make You Outstanding on the First Day of Your Career Just what combination of ingredients, exactly, makes an executive? What made them emerge and stand out as a leader? What is it companies are looking for, anyway? And how might you close the gap between what we learned in school and what it truly takes to stand out in the professional world? Author and CEO April Armstrong's The Day One Executive covers all this and more. A longtime trusted advisor to private industry and senior government officials, April has worked extensively with executives in the private sector and across the Executive Branch, including the White House and the U.S. Intelligence Community. She is the founder and CEO of AHA Insight, a strategic consulting firm for top executives, and joins the Book That Make You Show to break down just some of the wisdom found in her award-winning book. Find out more on Books That Make You. You can also follow us on Facebook and Instagram.

In this episode of Derms and Conditions, host James Q Del Rosso, DO, interviews Faranak Kamangar, MD, and April Armstrong, MD, MPH, about the integration of artificial intelligence (AI) in dermatology. They discuss specialized dermatologic models, ethical considerations, and the crucial role of physicians in refining these technologies. The discussion begins with the host addressing concerns regarding the "authenticity" of AI and how Dr Kamangar developed a strong interest in AI, stemming from her engineering background and interest in health technology, particularly in the development of language-learning models. She explains the significance of ChatGPT opening the door publicly for AI, followed by specialized models revolutionizing AI accuracy. They then discuss the vetting process for AI accuracy, addressing both anticipated and logical errors and the more subtle errors seen in field-specific results. Dr Kamangar emphasizes the importance of using specialized AI models for dermatology to ensure the most precise results. The discussion with both Dr Kamangar and Dr Armstrong also touches on the ethical considerations surrounding AI use in medical writing, highlighting the necessity of disclosing AI involvement to uphold integrity in academic publishing. Exploring the use of AI in electronic medical records (EMRs), Dr Kamangar and Armstrong underscore the importance of maintaining HIPAA compliance and the need for human oversight when integrating AI into EMRs and publications. They note that when implemented effectively, AI use in EMRs has the potential to reduce human errors, and with both medical record documentation and publication writing, has the potential to alleviate burnout. The conversation then shifts to the role of residents in integrating AI tools into their practice, with Dr Armstrong noting that residents are often early adopters of new technologies. They also emphasize the importance of physician involvement in the early development of dermatology-specific AI solutions, which is essential for shaping tools that address real-world challenges in dermatologic practice. Looking forward, they both anticipate continued integration of AI in dermatology practice, emphasizing the need for physicians to familiarize themselves with this technology to determine what models are dependable and ultimately to optimize patient care. Tune into the episode to further explore the many nuanced challenges and opportunities presented by AI adoption in dermatology!

Fungal nail disease can be challenging to diagnose and treat, especially when patients have concomitant diseases that can cause nail dystrophy. DERM faculty member April Armstrong, MD, MPH provides practical guidance on the diagnosis and management of nail disease. Also in this edition, DEF Founder Joe Gorelick, MSN, FNP-C reveals the 2024 Contact Allergen of the Year and DEF Advisory Council Member Andrea Nguyen, PA-C talks skincare.Like what you're hearing? Have a topic you want to hear more about? Hit us up and spread the word on Instagram!

In this episode of Derms and Conditions, our host, James Q. Del Rosso, DO, interviews April Armstrong, MD, MPH, a professor and Chief of Dermatology at UCLA, about the development of tapinarof, a novel nonsteroidal topical treatment for psoriasis.  They begin by discussing Dr Armstrong's history of professional interest in psoriasis. The conversation then moves to focus solely on tapinarof, a topical cream that works by modulating the aryl hydrocarbon receptor (AhR).  Dr Armstrong explains the unique mechanism of action of tapinarof and its effects on Th17 cytokines, antioxidant activity, and skin barrier function. She also discusses the efficacy demonstrated in clinical trials, with nearly 40% of patients achieving PASI 75 after 12 weeks, as well as the remittive effect in maintaining clear or almost clear skin.  They address the safety profile of tapinarof, including the occurrence of folliculitis and contact irritation, and provide tips for its use in clinical practice. Dr Armstrong also emphasizes its versatility and potential as a combination therapy with systemic medications. All in all, the episode provides listeners with an expansive understanding of tapinarof as an effective and well-tolerated nonsteroidal treatment for plaque psoriasis.

In this episode of Derms and Conditions, our host, James Q. Del Rosso, DO, is joined by April Armstrong, MD, MPH, and David Cohen, MD, MPH, live at Winter Clinical Hawaii 2024 to review highlights from the conference.  They cover a diverse slate of topics, including the 2023 allergen of the year (lanolin), notable advancements in psoriasis treatment including topicals and biologics, updates on diagnostic tools for melanoma, and clinical pearls for treating actinic keratosis with combinations of cryosurgery, topical field therapy, and PDT. The group reviews guidelines for atopic dermatitis and effective therapies like omalizumab and oral antihistamines for chronic spontaneous urticaria and secukinumab for hidradenitis suppurativa, as well as the need to improve outdated clinical guidance in the US.  Together, they examine the evolving role of artificial intelligence in dermatology and underscore the importance of practitioner well-being. From new therapies to new indications, tune in to hear a poignant analysis of key themes from the meeting this year.

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA. Launch Date: December 15, 2023Release Date: December 15, 2023Expiration Date: November 30, 2024FACULTY BIOSPhilip Mease, MD, MACRDirector, Rheumatology Research Swedish Medical Center/ Providence St. Joseph HealthClinical ProfessorUniversity of Washington School of MedicineApril Armstrong, MD, MPH     Professor and Chief Division of Dermatology       University of California Los AngelesThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA. Launch Date: December 15, 2023Release Date: December 15, 2023Expiration Date: November 30, 2024FACULTY BIOSPhilip Mease, MD, MACRDirector, Rheumatology Research Swedish Medical Center/ Providence St. Joseph HealthClinical ProfessorUniversity of Washington School of MedicineApril Armstrong, MD, MPH     Professor and Chief Division of Dermatology       University of California Los AngelesThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47

This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). During this podcast series, Drs Philip Mease and April Armstrong will inform and guide on keeping up with recent progress and safely integrating it into clinical treatment paradigms of PsA. Launch Date: December 15, 2023Release Date: December 15, 2023Expiration Date: November 30, 2024FACULTY BIOSPhilip Mease, MD, MACR Director, Rheumatology Research  Swedish Medical Center/ Providence St. Joseph Health Clinical Professor University of Washington School of MedicineApril Armstrong, MD, MPH     Professor and Chief  Division of Dermatology       University of California Los AngelesThis podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.https://www.practicepointcme.com/CMEHome/expert-insights-on-psa-how-do-personalized-treatment-options-transform-patient-outcomes-47 

In this episode, dermatologists Dr. April Armstrong and Dr. James Song discuss the impact of psoriasis on a patient's quality of life and how steroid-free prescription topical medications can meet the treatment needs of adults with plaque psoriasis. This Psound Bytes episode is sponsored by Dermavant Sciences. 

Dr. Kamangar chats with her mentor, Dr. April Armstrong, MD, recipient of the Lifetime Achievement Awards from the Psoriasis Foundation about her research on psoriasis therapies.

This livestream was recorded on August 25, 2023, at the SF Derm Society Eczema Symposium and 100 year Celebration with moderator Dr. Ekama Carlson, MD, PhD, and panelists Dr. John YM Koo, MD, Dr. April Armstrong, MD MPH, and Dr. Faranak Kamangar, MD. Panelists discuss the past, present, and future of dermatology along with Dr. Kamangar's new innovation DermGPT and the inclusion of AI.

Asia Kiniel talks with college students about balancing schoolwork with home life and raising their children. Guests include April Armstrong, Rickie Rembert, and Ja'Quan Hancock.

Cutaneous sarcoidosis and hidradenitis suppurativa are two diseases that can be particularly challenging for patients with skin of color. Ted Rosen, MD, FAAD, discusses the diagnosis and long-term management of these conditions. Plus, April Armstrong, MD, FAAD assesses the impact of dietary changes in psoriasis management, and Wendy Cantrell, DNP, CRNP, and Andrea Nguyen, PA-C, MPAS, talk about which tests they really use in the clinic.Like what you're hearing? Have a topic you want to hear more about? Hit us up and spread the word on Instagram!

Created by April Armstrong. Catch the MyTyme Only Podcast at: https://open.spotify.com/show/0mxCTEbMUz8vaM19jC3MyO Follow on social media: Facebook: https://www.facebook.com/profile.php?id=100090638371878 Instagram: https://www.instagram.com/mytymeonly YouTube: https://www.youtube.com/@mytymeonlypodcast8008

Every single person has the innate ability to become a good leader, and the only thing you have to do is tap this power deep within you. If you can embrace an executive mindset, you can rise to the challenge - right now. You don't have to wait for someone else to acknowledge your talents. April Armstrong, a certified expert facilitator and master executive coach, is a strong believer in this concept. She wrote all about it in her book, The Day One Executive. She joins Dom Brightmon to discuss how to behave and perform like a high-level executive on the go. April discusses the best ways to make yourself feel seen, be heard, and recognized as the skilled leader you truly are. Opening track is titled “Check It Out” by Mountaineer from #Uppbeat (free for Creators!):https://uppbeat.io/t/mountaineer/check-it-outLicense code: AR6DFPGVXQ9Q1SSY Please support today's podcast to keep this content coming! CashApp: $DomBrightmonDonate on PayPal: @DBrightmonBuy Me a Coffee: https://www.buymeacoffee.com/dombrightmonGet Going North T-Shirts, Stickers, and More: https://www.teepublic.com/stores/dom-brightmon You May Also Like… Ep. 306 – “Be The SPARK” with Dr. Simon T. Bailey (@SimonTBailey): https://www.goingnorthpodcast.com/ep-306-be-the-spark-with-simon-t-bailey-simontbailey/ Ep. 336.5 (H2H Special) – “Own Your Career Own Your Life” with Andy Storch (@AndyStorch): https://www.goingnorthpodcast.com/ep-3365-h2h-special-own-your-career-own-your-life-with-andy-storch-andystorch/ 270 – "Forever Employable" with Jeff Gothelf (@jboogie): https://www.goingnorthpodcast.com/270-forever-employable-with-jeff-gothelf-jboogie/ 254 – “The New Global Manager” with Melissa Lamson (@melissa_lamson1): https://www.goingnorthpodcast.com/254-the-new-global-manager-with-melissa-lamson-melissa_lamson1/ Ep. 348 – “Bring Inner Greatness Out” with Dr. Mansur Hasib, CISSP, PMP, CPHIMS (@mhasib): https://www.goingnorthpodcast.com/ep-348-bring-inner-greatness-out-with-dr-mansur-hasib-cissp-pmp-cphims-mhasib/ 289 – “You're Absolutely Worth It” with Velera Wilson (@VeleraWilson): https://www.goingnorthpodcast.com/289-youre-absolutely-worth-it-with-velera-wilson-velerawilson/ 265 – “Hitting Rock Middle” with Sallie Holder (@SallieHolder17): https://www.goingnorthpodcast.com/265-hitting-rock-middle-with-sallie-holder-sallieholder17/ Ep. 343 – “Thrive” with Andrew Freedman (@afreedmanthrive): https://www.goingnorthpodcast.com/ep-343-thrive-with-andrew-freedman-afreedmanthrive/ Ep. 327 – “The Go-Giver Way of Elite Performance” with Bob Burg (@BobBurg): https://www.goingnorthpodcast.com/ep-327-the-go-giver-way-of-elite-performance-with-bob-burg-bobburg/ 119 - "A Passion for High Performance & Professional Development" with Dr. Elizabeth Carter (@eacaappeal): https://www.goingnorthpodcast.com/119-a-passion-for-high-performance-professional-development-with-dr-elizabeth-carter-eacaappeal/ Ep. 322.5 (H2H Special) – “Burnout Proof” with Michael Levitt (@bfastleadership): https://www.goingnorthpodcast.com/ep-3225-h2h-special-burnout-proof-with-michael-levitt-bfastleadership/ 193 – “The Quest For Purpose” with Dr. Ken Keis (@crgleader): https://www.goingnorthpodcast.com/193-the-quest-for-purpose-with-dr-ken-keis-crgleader/ Ep. 420 – “The UPside of Failure” with Tiana Sanchez (@likearealboss): https://www.goingnorthpodcast.com/ep-420-the-upside-of-failure-with-tiana-sanchez-likearealboss/ 110 - "Self-Intelligence" with Jane Ransom (@TheJaneRansom): https://www.goingnorthpodcast.com/110-self-intelligence-with-jane-ransom-thejaneransom/ Ep. 359 – “Think Yourself Confident & Successful” with Nathalie Plamondon-Thomas (@thinkyourselfAc): https://www.goingnorthpodcast.com/ep-359-think-yourself-confident-successful-with-nathalie-plamondon-thomas-thinkyourselfac/ 74 - "Deciding to Soar" with SharRon Jamison (@SharRonJamison): https://www.goingnorthpodcast.com/74-deciding-to-soar-with-sharron-jamison-sharronjamison/

In episode 44 of Derms and Conditions, our host James Q. Del Rosso, DO sits down with April Armstrong, MD, MPH and David Cohen, MD, MPH, live at Winter Clinical Hawaii 2023 to discuss highlights from the meeting. The trio reviews important tips from a variety of topics, ranging from contact dermatitis to psoriasis. Many lectures from this meeting focused on the new biologics and JAK inhibitors available to treat inflammatory conditions such as psoriasis and atopic dermatitis. The group unpacks important considerations for each of these medications and how to effectively use them to improve patient outcomes. Finally, they discuss deucravacitinib and its unique mechanism of action of TYK2 inhibition. Tune in to hear our KOLs recap some of the best clinical pearls from the meeting!

April Armstrong, MD interviewed by Brad Glick, DO, MPH, FAAD

New ABOS President Dr. April Armstrong, the second woman to be President of the ABOS, discusses her goals for her one-year term.

EP. 114 - Did You Know that there are different types of the chronic skin disorder Psoriasis? And no one type of treatment works for everyone? On this episode, I am joined by Dermatologist Dr. April Armstrong, and Leah M. Howard, President & CEO of the National Psoriasis Foundation to talk about the challenges faced when living with Psoriasis, and a new once daily oral treatment option available to help people with Psoriasis manage their skin health better. #Health

In this bonus episode of the DIGA podcast, I talk with Dr. April Armstrong, Vice Chair of the Department of Dermatology at the University of Southern California, Director of Clinical Trials and Outcomes Research, and Director of the Psoriasis Program. Actually, these are only about 1% of Dr. Armstrong's titles, as you will learn later on in this episode! We talk about her journey to dermatology, how medical students can get involved in research, and how professional societies can both help students and residents in their careers and become a conduit for students and residents to give back. Links: CalDerm Website CalDerm Fall Symposium Registration Dr. April Armstrong Lab Music: District Four by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3662-district-four License: https://filmmusic.io/standard-license --- Send in a voice message: https://anchor.fm/derminterest/message

CME credits: 0.50 Valid until: 25-02-2023 Claim your CME credit at https://reachmd.com/programs/cme/raising-the-bar-in-psa-integrating-structural-assessment-to-improve-long-term-outcomes/13301/ Integrating routine assessments of psoriatic arthritis (PsA)-related structural progression has proven challenging in clinical practice. Join Drs. Sergio Schwartzman, Philip Mease, and April Armstrong as they discuss evidence that frequent monitoring of PsA structural progression permits earlier intervention with effective therapies as well as provides indications for when to switch to another class of agent. They also address which therapeutic agents have been shown to impact PsA structural progression in clinical trials and provide insight into how best to incorporate collaborative treatment strategies across disciplines. These practices are likely to improve outcomes for patients with PsA, so be sure to stay informed.

CME credits: 0.50 Valid until: 25-02-2023 Claim your CME credit at https://reachmd.com/programs/cme/raising-the-bar-in-psa-integrating-structural-assessment-to-improve-long-term-outcomes/13301/ Integrating routine assessments of psoriatic arthritis (PsA)-related structural progression has proven challenging in clinical practice. Join Drs. Sergio Schwartzman, Philip Mease, and April Armstrong as they discuss evidence that frequent monitoring of PsA structural progression permits earlier intervention with effective therapies as well as provides indications for when to switch to another class of agent. They also address which therapeutic agents have been shown to impact PsA structural progression in clinical trials and provide insight into how best to incorporate collaborative treatment strategies across disciplines. These practices are likely to improve outcomes for patients with PsA, so be sure to stay informed.

In episode 19 of Derms and Conditions, our host James Q. Del Rosso, DO speaks with David Cohen, MD, MPH and April Armstrong, MD, MPH in front of a live audience during the 2022 Winter Clinical Dermatology Conference from Koloa, Hawaii. Dr. Del Rosso asks his two guests what they thought were the highlights from the many great lectures delivered at this meeting. Dr. Cohen discusses updates in the treatment of Chronic Spontaneous Urticaria and specifically mentions the use of omalizumab. Dr. Armstrong highlights a new cream based formulation of calcipotriene-betamethasone and two new non-steroidal topical options for the treatment of psoriasis in the pipeline. Dr. Armstrong also highlights pearls from Dr. Kirby's lecture on HS including the use of antibiotics and proper injections techniques for steroids. The episode ends with Dr. Cohen's discussion of the allergen of the year and Dr. Armstrong's discussion on the use of oral minoxidil in the treatment of hair loss. 

Episode 17 of Derms and Conditions has our host James Q. Del Rosso, DO speaking with April Armstrong, MD, MPH, Professor of Dermatology at The University of Southern California. In this episode, Dr. Del Rosso and Dr. Armstrong discuss high yield pearls in managing difficult and treatment resistant cases of atopic dermatitis and psoriasis. Specifically, they discuss bridging a patient to dupilumab with cyclosporine, how to effectively switch between different biologic therapies for psoriasis, and how to use apremilast effectively in patients with severe psoriasis. Finally, Dr. Del Rosso asks Dr. Armstrong about best practices for vaccination in patients on oral and biologic therapies for psoriasis and atopic dermatitis. 

Listen to dermatologist Dr. April Armstrong and rheumatologist Dr. Philip Mease as they discuss managing psoriasis and psoriatic arthritis in aging populations. For disclosures/credit: https://www.eeds.com/em/3582 This program is supported by educational grants from Bristol Myers Squibb, Lilly, Novartis and Ortho Dermatologics.

In this episode of the American Shoulder and Elbow Surgeons Podcast, hosts Dr. Rachel Frank and Dr. Peter Chalmers interview Drs. David Martin and April Armstrong on their roles with the ABOS. 

Hosts Gregg Masters and Fred Goldstein meet April Armstrong, MD, MPH Professor of Dermatology and Associate Dean at USC. Dr. Armstrong to discusses psoriasis, a chronic and systemic inflammatory skin disease affecting children as well as adults and the tremendous impact on their physical and mental impact on quality of life. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

This episode of the AMCP Podcast Series powered by PopHealth Week features April Armstrong, MD, MPH. Health care expert Fred Goldstein of AMCP Podcast Powered by PopHealth Week sits down with Dr. April Armstrong to discuss psoriasis, a chronic and systemic inflammatory skin disease affecting children as well as adults and the tremendous impact on their physical and mental impact on quality of life. Dr. Armstrong is a general dermatologist with a focus on inflammatory skin diseases, and those include psoriasis and atopic dermatitis. She also treats patients with hidradenitis suppurativa, conducts research, and specifically looks at some of the systemic therapies and how they impact patients with inflammatory skin diseases.  Dr. Armstrong is Professor of Dermatology and Associate Dean at the University of Southern California (USC). She also serves as Vice Chair in the dermatology department and heads the psoriasis program at USC. Dr. Armstrong obtained her medical degree from Harvard Medical School and completed dermatology residency at Harvard. She also obtained a Master of Public Health degree from Harvard School of Public Health. Prior to joining faculty at the University of Southern California, Dr. Armstrong was Vice Chair at the University of California Davis in Sacramento and later at the University of Colorado in Denver. This episode is sponsored by UCB Pharmaceuticals. For more information on UCB Pharmaceuticals go to www.ucb-usa.com and do visit the AMCP Podcast Series powered by PopHealth Week, at www.AMCP.org/podcast ==##==

This episode of the AMCP Podcast Series powered by PopHealth Week features April Armstrong, MD, MPH. Health care expert Fred Goldstein of AMCP Podcast Powered by PopHealth Week sits down with Dr. April Armstrong to discuss psoriasis, a chronic and systemic inflammatory skin disease affecting children as well as adults and the tremendous impact on their physical and mental impact on quality of life. Dr. Armstrong is a general dermatologist with a focus on inflammatory skin diseases, and those include psoriasis and atopic dermatitis. She also treats patients with hidradenitis suppurativa, conducts research, and specifically looks at some of the systemic therapies and how they impact patients with inflammatory skin diseases.  Dr. Armstrong is Professor of Dermatology and Associate Dean at the University of Southern California (USC). She also serves as Vice Chair in the dermatology department and heads the psoriasis program at USC. Dr. Armstrong obtained her medical degree from Harvard Medical School and completed dermatology residency at Harvard. She also obtained a Master of Public Health degree from Harvard School of Public Health. Prior to joining faculty at the University of Southern California, Dr. Armstrong was Vice Chair at the University of California Davis in Sacramento and later at the University of Colorado in Denver. This episode is sponsored by UCB Pharmaceuticals. For more information on UCB Pharmaceuticals go to www.ucb-usa.com and do visit the AMCP Podcast Series powered by PopHealth Week, at www.AMCP.org/podcast ==##==  

Host: Matt Birnholz, MD Guest: April Armstrong, MD, MPH Guest: Laura Ferris, MD, PhD When dermatologists and psoriasis patients fail to align on treatment expectations, this can lead to missed opportunities in achieving higher levels of skin clearance. Fortunately, utilizing certain therapeutic and counseling strategies can help dermatologists better align with their patients and improve their standards of care. Joining Dr. Matt Birnholz to share these practical strategies are Drs. April Armstrong and Laura Ferris. VERSION 1.0 | MAY 2021 | ABBV-US-00466-MC

Hear Corey's journey with moderate-to-severe plaque psoriasis and the physical, social and emotional impact it had on his life. Dr. April Armstrong, Associate Dean of Clinical Research at the Keck School of Medicine at USC, joins to offer advice for how to manage your symptoms and discusses a treatment option for moderate-to-severe plaque psoriasis. This episode is sponsored by Sun Pharma. For more important Safety Information: https://bit.ly/2We7fIS .

Guest: April Armstrong, MD, MPH Psoriasis can have significant emotional and psychosocial impact on patients. There is a need to set concrete therapeutic goals for our patients with moderate-to-severe plaque psoriasis. That’s why leading dermatologist Dr. April Armstrong from the Keck School of Medicine at USC is here to discuss how we can make clear or almost clear skin an achievable target and have a shared therapeutic outlook with patients. VERSION 1.0 | APRIL 2021 | ABBV-US-00445-MC

Guest: April Armstrong, MD, MPH Since we’re starting to reevaluate how we think about psoriasis severity and which patients are eligible for systemic therapies, Dr. April Armstrong leading dermatologist from University of Southern California is here to walk us through how traditional classifications of disease severity may not be sufficient to reflect the full impact of psoriasis on patients. VERSION 1.0 | APRIL 2021 | ABBV-US-00440-MC

  Dr April Armstrong is a rural GP with a passion for business.  She is the CEO of Business For Doctors, a social network and business advisory firm for Australian clinicians to help them run a better business. In addition to that, she owns two medical practices and has won a bunch of awards and invested in various initiatives supporting health care.  She also actively supports medical students and overseas trained doctors during their transition into the Australian medical system. In this interview you will hear the April Armstrong story (a fascinating one filled with babies, farms and private investigators…) as well as the origins of Business For Doctors. April provides insights into the history of Medicare and shares her thoughts on the handling of telehealth billing.  She also covers the joys of providing a healthcare service in rural and regional Australia. More information and full show notes located here.

From diagnosis to therapy options nail psoriasis can be a challenge to treat. Listen as leading dermatologist and NPF Medical Board Member, Dr. April Armstrong, Director of the Psoriasis Program, Dept. of Dermatology at Keck School of Medicine, USC, addresses the challenges and offers tips to help manage nail psoriasis. For disclosure information and claim credit go to https://www.eeds.com/em/1271. For more information read the JPPA article "Nail Psoriasis: A Review of Treatment Options" https://journals.sagepub.com/doi/pdf/10.1177/247553031016.00405. This activity is supported by grant funding from AbbVie, Amgen and Lilly. 

What's the association between diet choices and psoriatic disease severity? Hear the evidence and current research around dietary recommendations from dermatologist Dr. April Armstrong, Director of the Psoriasis Program, Dept. of Dermatology at Keck School of Medicine, University of Southern California. To view disclosure information and claim credit, go to https://www.eeds.com/em/1138 . To access the full recommendations: https://jamanetwork.com/journals/jamadermatology/article-abstract/2684587. 

Dr April Armstrong is a UWA graduate of Medicine and works in General Practice in Western Australia. She is passionate about the business of medicine and is the founder of the Business for Doctors concept and social media group. April was awarded the WA Telstra Business Woman of the Year 2015 in the start-up category and her rural practice, Collins Street Surgery nominated for the WA Telstra Business Awards 2015. As an owner of two medical practices and numerous investments she brings 25 years of business and investing experience to health professionals wanting to learn more about all facets of business and life in medicine.  https://businessfordoctors.com/ https://www.facebook.com/groups/businessfordoctors/   Conflicts of interest: Obviously Dr Armstrong's expenses are covered during her work for BFD.   More information at www.facebook.com/thegpshow.podcast As always - Rating 5 stars +/- a review on iTunes is a great help     Enjoy Friends